Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. has discovered new glucocorticoid receptor (GR) agonists potentially useful for the treatment of rheumatoid arthritis, idiopathic arthritis, systemic lupus erythematosus, asthma, ulcerative colitis, neuromyelitis optica and autoimmune liver disease.